GSK Makes $24M Demand As Hospira Trial Wraps
A subsidiary of GlaxoSmithKline told an Illinois federal jury on Wednesday that Hospira should pay up to $24 million for breaching a contract to fill syringes with a GSK-manufactured flu vaccine,...To view the full article, register now.
Already a subscriber? Click here to view full article